Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

NCT05804370 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
170
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

NX Development Corp